Target intelligence / Profile preview

Cell binding domain of type I collagen

Molecular classification
Protein domain/structural motif within extracellular matrix protein
01

Overview

The cell binding domain of type I collagen is a specific peptide sequence within the larger type I collagen protein that mediates binding to cell-surface receptors, mainly integrins (e.g., α2β1) and fibronectin. These domains include motifs adjacent to the matrix metalloprotease-1 (MMP-1) cleavage site and other sites within the triple-helical region of collagen, often characterized by Gly-X-Y repeat motifs such as GFOGER or GLOGER. These regions facilitate cell adhesion, trigger intracellular signaling, and coordinate extracellular matrix remodeling essential for tissue homeostasis and development. The cell binding domain is instrumental in physiological processes like wound healing and pathological states, including cancer invasion and tissue fibrosis, but is not a discrete pharmacological target itself.

Other names
fibronectin-binding site of type I collagenintegrin-binding site of type I collagencollagen cell-binding motif
02

Mechanism of action

Not applicable as a standalone therapeutic target, but the mechanism for blockers is disruption of collagen–integrin or collagen–fibronectin interactions.

03

Biological functions

Cell-matrix adhesionSignal transduction (via integrin engagement)Extracellular matrix remodelingTissue organization
04

Disease associations

Cancer (via altered cell-matrix interactions and tissue remodeling)Fibrosis (ECM remodeling)Wound healingInfection (via bacterial adhesins hijacking collagen binding)
05

Safety considerations

Impaired wound healingTissue repair impairmentECM function impairment if broadly inhibited

Beyond the preview

Go deeper on Cell binding domain of type I collagen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell binding domain of type I collagen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call